Nova Nordisk Announces Partnership To Treatment Cardiometabolic Disease

Novo Nordisk Collaborates with Omega Therapeutics and Cellarity for Groundbreaking Cardiometabolic Disease Treatment.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In a significant step towards addressing cardiometabolic diseases, Danish multinational pharmaceutical company Novo Nordisk has entered into research collaborations with US-based biotech firms, Omega Therapeut…